newsfilter
← Latest News
Business Wire·

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

-- Conference Call Today at 5:00 p.m. Eastern Time -- MEI Pharma, Inc. (NASDAQ:MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its fiscal year